Prudential Financial’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-639	Closed	-$57.9K	–	2725
2023 Q1	$57.9K	Sell	639 -152	-19%	-$13.8K	﹤0.01%	2486
2022 Q4	$93.4K	Hold	791	–	–	﹤0.01%	2455
2022 Q3	$144K	Buy	791 +52	+7%	+$9.47K	﹤0.01%	2489
2022 Q2	$66K	Buy	+739	New	+$66K	﹤0.01%	2553